Biography
As Assistant Director, Kim is responsible for oversight of the 20+ member Research Pharmacy team. The Research Pharmacy team supports over 600+ clinical trials and 9000+ dispenses each year. She serves as Residency Program Director for the PGY1-PGY2 Investigational Drugs and Research Pharmacy residency, and offers rotations related to practice management and leadership. She also precepts writing and research projects.
Pharmacy School Attended: St Louis College of Pharmacy (1989 and 1990)
Additional Training: Hennepin County Medical Center, Drug Evaluation Unit Residency (1991)
Areas of Interest: Research ethics and compliance, leadership and management, expanded access.
Honors & Awards:
- National Organization for Rare Diseases (NORD) Top Abstract Award (2020)
Publications:
- Song K, Yu M, McLuckie R, O'Brien K, Harrison M, Nguyen V, Kraft M, Abdelghany O, Phillips MS, Roberts J, Johnston S, Young CA, Redic KA. Development of complexity categories for an investigational drug services complexity scoring tool to assess pharmacy effort in clinical trial initiation and maintenance. Am J Health Syst Pharm. 2023 Oct 25;80(21):1557-1563. doi: 10.1093/ajhp/zxad138. PMID: 37335865.
- Scott, Andrew J... Redic KA, et al. "Rewiring of cortical glucose metabolism fuels human brain cancer growth." medRxiv (2023): 2023‐10.
- Smith AJF, Redic KA. Single-patient expanded access: a primer for pharmacists. Am J Health-system Pharm, Volume 79: 2118–2127, December 1, 2022. https://doi.org/10.1093/ajhp/zxac242
- Amin S, Polley S, DeFrates S, Finnes HD, et al. National Comprehensive Cancer Network investigational drug service consensus recommendations. Am J Health-system Pharm, 79: 486–491, March15, 2022. https://doi.org/10.1093/ajhp/zxab455.
- Siden R, Modlin J, Lee-Gabel L, Redic KA. Handout for research subjects receiving investigational oral chemotherapy. Am J Health-system Pharm, 76:2009–2012, December 15, 2019, https://doi.org/10.1093/ajhp/zxz239.
- Chaffee BW, Lander MJ, Christen C, Redic KA. Surface contamination of counting tools after mock dispensing of cyclophosphamide in a simulated outpatient pharmacy. Journal of Oncology Pharmacy Practice. First published March 29, 2018. https://doi.org/10.1177/1078155218764587.
- Redic KA, Skyles AJ, Zaccardelli J. Potential role of a pharmacist to enhance medication-related aspects of clinical trials conducted in a dedicated clinical research unit. Contemp Clin Trials Comm:6:55-57. 2017
- Redic KA, Fang K, Christen C, Chaffee B. Surface contamination of hazardous drug pharmacy storage bins and pharmacy distributor shipping containers. J Oncol Pharm Practice: November 17, 2016.
- Redic KA, Hough SM, Price EM. Clinical developments in the treatment of relapsed or relapsed and refractory multiple myeloma: impact of panobinostat, the first-in-class histone deacetylase inhibitor. OncoTarg Ther: 9:2783—2793, 2016.
- Ashjian E and Redic K. Multiple myeloma: Updates for pharmacists in the treatment of relapsed and refractory disease. J Oncol Pharm Pract 22: 289 - 302. 2015
- Siden R, Tamer HR, Skyles AJ, Dolan CS, Propes DJ, Redic K. Survey to assess the role of pharmacy technicians and non-pharmacist staff in the operation of research pharmacies. Am J Health Syst Pharm:71:1877-1889, 2014.
- Redic K. Carfilzomib: A Novel Agent for Multiple Myeloma. J Pharm Pharmacology 65(8):1095-1106, 2013.
- Skyles AJ, Tamer HR, Redic KA, Loo A, Mason NA. Investigational drug service advanced pharmacy practice experience (APPE), Currents in Pharm Teaching Learning 5:134-139, 2013.